Suppr超能文献

种族、血清钾水平及其与终末期肾病和死亡率的关联。

Race, Serum Potassium, and Associations With ESRD and Mortality.

作者信息

Chen Yan, Sang Yingying, Ballew Shoshana H, Tin Adrienne, Chang Alex R, Matsushita Kunihiro, Coresh Josef, Kalantar-Zadeh Kamyar, Molnar Miklos Z, Grams Morgan E

机构信息

Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD.

Division of Nephrology, Geisinger Health System, Danville, PA.

出版信息

Am J Kidney Dis. 2017 Aug;70(2):244-251. doi: 10.1053/j.ajkd.2017.01.044. Epub 2017 Mar 28.

Abstract

BACKGROUND

Recent studies suggest that potassium levels may differ by race. The basis for these differences and whether associations between potassium levels and adverse outcomes differ by race are unknown.

STUDY DESIGN

Observational study.

SETTING & PARTICIPANTS: Associations between race and potassium level and the interaction of race and potassium level with outcomes were investigated in the Racial and Cardiovascular Risk Anomalies in Chronic Kidney Disease (RCAV) Study, a cohort of US veterans (N=2,662,462). Associations between African ancestry and potassium level were investigated in African Americans in the Atherosclerosis Risk in Communities (ARIC) Study (N=3,450).

PREDICTORS

Race (African American vs non-African American and percent African ancestry) for cross-sectional analysis; serum potassium level for longitudinal analysis.

OUTCOMES

Potassium level for cross-sectional analysis; mortality and end-stage renal disease for longitudinal analysis.

RESULTS

The RCAV cohort was 18% African American (N=470,985). Potassium levels on average were 0.162mmol/L lower in African Americans compared with non-African Americans, with differences persisting after adjustment for demographics, comorbid conditions, and potassium-altering medication use. In the ARIC Study, higher African ancestry was related to lower potassium levels (-0.027mmol/L per each 10% African ancestry). In both race groups, higher and lower potassium levels were associated with mortality. Compared to potassium level of 4.2mmol/L, mortality risk associated with lower potassium levels was lower in African Americans versus non-African Americans, whereas mortality risk associated with higher levels was slightly greater. Risk relationships between potassium and end-stage renal disease were weaker, with no difference by race.

LIMITATIONS

No data for potassium intake.

CONCLUSIONS

African Americans had slightly lower serum potassium levels than non-African Americans. Consistent associations between potassium levels and percent African ancestry may suggest a genetic component to these differences. Higher and lower serum potassium levels were associated with mortality in both racial groups.

摘要

背景

近期研究表明,血钾水平可能因种族而异。这些差异的基础以及血钾水平与不良结局之间的关联是否因种族不同而存在差异尚不清楚。

研究设计

观察性研究。

研究地点与参与者

在慢性肾脏病种族与心血管风险异常(RCAV)研究中,对美国退伍军人队列(N = 2,662,462)的种族与血钾水平之间的关联以及种族和血钾水平与结局的相互作用进行了研究。在社区动脉粥样硬化风险(ARIC)研究中的非裔美国人(N = 3,450)中,对非洲血统与血钾水平之间的关联进行了研究。

预测因素

用于横断面分析的种族(非裔美国人与非非裔美国人以及非洲血统百分比);用于纵向分析的血清钾水平。

结局指标

用于横断面分析的血钾水平;用于纵向分析的死亡率和终末期肾病。

结果

RCAV队列中18%为非裔美国人(N = 470,985)。与非非裔美国人相比,非裔美国人的血钾水平平均低0.162mmol/L,在对人口统计学、合并症和使用改变血钾的药物进行调整后,差异仍然存在。在ARIC研究中,非洲血统比例越高,血钾水平越低(每增加10%非洲血统,血钾水平降低-0.027mmol/L)。在两个种族组中,血钾水平的升高和降低均与死亡率相关。与血钾水平为4.2mmol/L相比,非裔美国人血钾水平较低时的死亡风险低于非非裔美国人,而血钾水平较高时的死亡风险略高。血钾与终末期肾病之间的风险关系较弱,且种族间无差异。

局限性

无钾摄入量数据。

结论

非裔美国人的血清钾水平略低于非非裔美国人。血钾水平与非洲血统百分比之间的一致关联可能表明这些差异存在遗传因素。两个种族组中,血钾水平的升高和降低均与死亡率相关。

相似文献

1
Race, Serum Potassium, and Associations With ESRD and Mortality.
Am J Kidney Dis. 2017 Aug;70(2):244-251. doi: 10.1053/j.ajkd.2017.01.044. Epub 2017 Mar 28.
3
Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort.
Am J Nephrol. 2017;45(6):509-521. doi: 10.1159/000475997. Epub 2017 May 20.
4
Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
Am J Nephrol. 2015;41(6):456-63. doi: 10.1159/000437151. Epub 2015 Jul 25.
5
Serum potassium and the racial disparity in diabetes risk: the Atherosclerosis Risk in Communities (ARIC) Study.
Am J Clin Nutr. 2011 May;93(5):1087-91. doi: 10.3945/ajcn.110.007286. Epub 2011 Mar 2.
7
Racial differences in the competing risks of mortality and ESRD after acute myocardial infarction.
Am J Kidney Dis. 2008 Aug;52(2):251-61. doi: 10.1053/j.ajkd.2008.03.019. Epub 2008 May 12.
8
Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis.
Am J Nephrol. 2015;42(1):25-34. doi: 10.1159/000438999. Epub 2015 Aug 20.
9
Survival Disparity of African American Versus Non-African American Patients With ESRD Due to SLE.
Am J Kidney Dis. 2015 Oct;66(4):630-7. doi: 10.1053/j.ajkd.2015.04.011. Epub 2015 May 19.
10
Asymmetric dimethylarginine, race, and mortality in hemodialysis patients.
Clin J Am Soc Nephrol. 2014 Aug 7;9(8):1426-33. doi: 10.2215/CJN.00770114. Epub 2014 Jun 26.

引用本文的文献

1
Hypokalaemia in pregnancy - Prevalence, underlying causes, and an approach to investigation.
Obstet Med. 2024 Dec;17(4):213-220. doi: 10.1177/1753495X231213537. Epub 2023 Nov 29.
2
Sacubitril-Valsartan in Patients Requiring Hemodialysis.
JAMA Netw Open. 2024 Aug 1;7(8):e2429237. doi: 10.1001/jamanetworkopen.2024.29237.
3
The relationship between potassium levels and 28-day mortality in sepsis patients: Secondary data analysis using the MIMIC-IV database.
Heliyon. 2024 May 22;10(11):e31753. doi: 10.1016/j.heliyon.2024.e31753. eCollection 2024 Jun 15.
4
6
Hyperkalemia in CKD: an overview of available therapeutic strategies.
Front Med (Lausanne). 2023 Jul 31;10:1178140. doi: 10.3389/fmed.2023.1178140. eCollection 2023.
9
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers.
Int J Mol Sci. 2022 Jun 7;23(12):6378. doi: 10.3390/ijms23126378.
10
Hypokalaemia associated with hydrochlorothiazide used in the treatment of hypertension in NHANES 1999-2018.
J Hum Hypertens. 2023 May;37(5):354-362. doi: 10.1038/s41371-022-00704-x. Epub 2022 May 6.

本文引用的文献

1
Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.
Mayo Clin Proc. 2016 Oct;91(10):1403-1412. doi: 10.1016/j.mayocp.2016.05.018. Epub 2016 Aug 4.
2
Achieving the Benefits of a High-Potassium, Paleolithic Diet, Without the Toxicity.
Mayo Clin Proc. 2016 Apr;91(4):496-508. doi: 10.1016/j.mayocp.2016.01.012. Epub 2016 Mar 3.
3
Genetic African Ancestry and Markers of Mineral Metabolism in CKD.
Clin J Am Soc Nephrol. 2016 Apr 7;11(4):653-62. doi: 10.2215/CJN.08020715. Epub 2016 Feb 8.
4
Candidate Surrogate End Points for ESRD after AKI.
J Am Soc Nephrol. 2016 Sep;27(9):2851-9. doi: 10.1681/ASN.2015070829. Epub 2016 Feb 8.
5
6
Hyperkalemia.
JAMA. 2015 Dec 8;314(22):2405-6. doi: 10.1001/jama.2015.9230.
7
Association between Serum Potassium and Outcomes in Patients with Reduced Kidney Function.
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):90-100. doi: 10.2215/CJN.01730215. Epub 2015 Oct 23.
8
Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans.
Circulation. 2015 Oct 20;132(16):1538-48. doi: 10.1161/CIRCULATIONAHA.114.015124. Epub 2015 Sep 18.
9
Acute Kidney Injury After Major Surgery: A Retrospective Analysis of Veterans Health Administration Data.
Am J Kidney Dis. 2016 Jun;67(6):872-80. doi: 10.1053/j.ajkd.2015.07.022. Epub 2015 Sep 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验